Over the past year, the question has been coming in from everywhere – from my patients and family members, from colleagues ...

Scientists from the University of Copenhagen say they have developed a drug that decreases appetite while increasing calorie ...

Novo Nordisk is working on a new obesity drug that could help patients shed more than any other weight-loss drug on the ...

SUMMT has shown for the first time that a drug can reduce major heart failure clinical outcomes in patients with heart ...

As optimism for GLP-1 receptor agonists for weight loss has grown, so too has their use in children. Currently, liraglutide ...

Ozempic, Wegovy and other GLP-1 drugs have been shown to curb alcoholism, a new study suggests. Researchers explain why ...

A new joint study by the University of Eastern Finland and Karolinska Institutet in Sweden found that the GLP-1 agonists ...

Researchers looked at the health records of 17 million Americans with obesity and determined that between 2022 and 2023, ...

In the United Kingdom, the government is hoping weight loss drugs might improve public finances, eyeing their use to help ...

Popular weight-loss drug Wegovy maker Novo Nordisk expects high demand and acceptance for its anti-obesity drug, when ...

Viking Therapeutics shares climbed 9% on Monday after the drug developer's oral obesity treatment helped reduce body weight ...

A recent study found semaglutide – the drug known as Ozempic – can improve knee pain in people with obesity and ...